Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 30, 2019
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
Wed, May 29, 2019
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
Oren Livnat Maintained (CARA) at Strong Buy with Increased Target to $28 on, May 29th, 2019
Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $26 to $28 on, May 29th, 2019.
Oren has made no other calls on CARA in the last 4 months.
There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Matthew Andrews of "Jefferies" Initiated at Strong Buy and Held Target at $22 on, Wednesday, February 6th, 2019
Similar Stocks and Investing Articles
[ Tue, Apr 09th 2019
] - WOPRAI
[ Fri, Sep 21st 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Wed, May 23rd 2018
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI
[ Tue, Feb 24th 2015
] - WOPRAI
[ Fri, Aug 29th 2014
] - WOPRAI